# BOK Financial Corp: financial statements, quarterly

BOKF · Nasdaq · CIK 875357 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bokf.md) · [Financials](/companies/bokf/financials.md) · [Filings](/companies/bokf/filings.md) · [Insiders](/companies/bokf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bokf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [316](/filings/0000875357-23-000046.md) | [342 d](/filings/0000875357-24-000008.md) | [352](/filings/0000875357-24-000023.md) | [376](/filings/0000875357-24-000041.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [33.3](/filings/0000875357-24-000050.md) | [29.0 d](/filings/0000875357-26-000013.md) | [23.2](/filings/0000875357-25-000027.md) | [47.3](/filings/0000875357-25-000045.md) | [33.3](/filings/0000875357-25-000057.md) | [39.3 d](/filings/0000875357-26-000013.md) | [35.0](/filings/0000875357-26-000034.md) | [40.7](/filings/0000875357-26-000048.md) | [35.7](/filings/0000875357-25-000057.md) | [51.2 d](/filings/0000875357-26-000013.md) | [43.9](/filings/0000875357-26-000034.md) | [51.1](/filings/0000875357-26-000048.md) |
| Net income | $m | [134](/filings/0000875357-24-000050.md) | [82.6 d](/filings/0000875357-26-000013.md) | [83.7](/filings/0000875357-25-000027.md) | [164](/filings/0000875357-25-000045.md) | [140](/filings/0000875357-25-000057.md) | [136 d](/filings/0000875357-26-000013.md) | [120](/filings/0000875357-26-000034.md) | [140](/filings/0000875357-26-000048.md) | [141](/filings/0000875357-25-000057.md) | [177 d](/filings/0000875357-26-000013.md) | [156](/filings/0000875357-26-000034.md) | [177](/filings/0000875357-26-000048.md) |
| Diluted EPS | $ per share | [2.04](/filings/0000875357-24-000050.md) | not reported | [1.29](/filings/0000875357-25-000027.md) | [2.54](/filings/0000875357-25-000045.md) | [2.18](/filings/0000875357-25-000057.md) | not reported | [1.86](/filings/0000875357-26-000034.md) | [2.19](/filings/0000875357-26-000048.md) | [2.22](/filings/0000875357-25-000057.md) | not reported | [2.58](/filings/0000875357-26-000034.md) | [2.92](/filings/0000875357-26-000048.md) |
| Basic EPS | $ per share | [2.04](/filings/0000875357-24-000050.md) | not reported | [1.29](/filings/0000875357-25-000027.md) | [2.54](/filings/0000875357-25-000045.md) | [2.18](/filings/0000875357-25-000057.md) | not reported | [1.86](/filings/0000875357-26-000034.md) | [2.19](/filings/0000875357-26-000048.md) | [2.22](/filings/0000875357-25-000057.md) | not reported | [2.58](/filings/0000875357-26-000034.md) | [2.92](/filings/0000875357-26-000048.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [48.9](/filings/0000875357-23-000046.md) | [49.8](/filings/0000875357-25-000013.md) | [50.2](/filings/0000875357-24-000023.md) | [50.4](/filings/0000875357-24-000041.md) | [50.1](/filings/0000875357-24-000050.md) | [49.7](/filings/0000875357-26-000013.md) | [50.5](/filings/0000875357-25-000027.md) | [51.0](/filings/0000875357-25-000045.md) | [50.2](/filings/0000875357-25-000057.md) | [52.2](/filings/0000875357-26-000048.md) | [53.8](/filings/0000875357-26-000034.md) | [53.2](/filings/0000875357-26-000048.md) |
| Total liabilities | $bn | [44.1](/filings/0000875357-23-000046.md) | [44.7](/filings/0000875357-25-000013.md) | [45.0](/filings/0000875357-24-000023.md) | [45.2](/filings/0000875357-24-000041.md) | [44.5](/filings/0000875357-24-000050.md) | [44.1](/filings/0000875357-26-000013.md) | [44.7](/filings/0000875357-25-000027.md) | [45.1](/filings/0000875357-25-000045.md) | [44.2](/filings/0000875357-25-000057.md) | [46.3](/filings/0000875357-26-000048.md) | [47.8](/filings/0000875357-26-000034.md) | [47.1](/filings/0000875357-26-000048.md) |
| Long-term debt | $bn | not reported | [9.0](/filings/0000875357-26-000013.md) | not reported | not reported | not reported | [4.5](/filings/0000875357-26-000013.md) | not reported | not reported | not reported | [4.6](/filings/0000875357-26-000013.md) | not reported | not reported |
| Shareholders' equity | $bn | [4.8](/filings/0000875357-23-000046.md) | [5.1](/filings/0000875357-25-000013.md) | [5.1](/filings/0000875357-24-000023.md) | [5.2](/filings/0000875357-24-000041.md) | [5.6](/filings/0000875357-24-000050.md) | [5.5](/filings/0000875357-26-000013.md) | [5.8](/filings/0000875357-25-000027.md) | [5.9](/filings/0000875357-25-000045.md) | [6.0](/filings/0000875357-25-000057.md) | [5.9](/filings/0000875357-26-000048.md) | [6.0](/filings/0000875357-26-000034.md) | [6.1](/filings/0000875357-26-000048.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,088 d](/filings/0000875357-24-000050.md) | [(462) d](/filings/0000875357-26-000013.md) | [179](/filings/0000875357-25-000027.md) | [464 d](/filings/0000875357-25-000045.md) | [247 d](/filings/0000875357-25-000057.md) | [541 d](/filings/0000875357-26-000013.md) | [20.3](/filings/0000875357-26-000034.md) | [89.4 d](/filings/0000875357-26-000048.md) | [868 d](/filings/0000875357-25-000057.md) | [(238) d](/filings/0000875357-26-000013.md) | [(249)](/filings/0000875357-26-000034.md) | [1,123 d](/filings/0000875357-26-000048.md) |
| Capital expenditure | $m | [31.0 d](/filings/0000875357-24-000050.md) | [37.0 d](/filings/0000875357-26-000013.md) | [40.9](/filings/0000875357-25-000027.md) | [46.4 d](/filings/0000875357-25-000045.md) | [37.2 d](/filings/0000875357-25-000057.md) | [47.1 d](/filings/0000875357-26-000013.md) | [48.2](/filings/0000875357-26-000034.md) | [28.6 d](/filings/0000875357-26-000048.md) | [29.3 d](/filings/0000875357-25-000057.md) | [58.3 d](/filings/0000875357-26-000013.md) | [35.7](/filings/0000875357-26-000034.md) | [47.2 d](/filings/0000875357-26-000048.md) |
| Dividends paid | $m | [35.6 d](/filings/0000875357-24-000050.md) | [35.7 d](/filings/0000875357-26-000013.md) | [35.6](/filings/0000875357-25-000027.md) | [35.4 d](/filings/0000875357-25-000045.md) | [35.1 d](/filings/0000875357-25-000057.md) | [36.9 d](/filings/0000875357-26-000013.md) | [36.5](/filings/0000875357-26-000034.md) | [36.5 d](/filings/0000875357-26-000048.md) | [36.3 d](/filings/0000875357-25-000057.md) | [38.2 d](/filings/0000875357-26-000013.md) | [37.6](/filings/0000875357-26-000034.md) | [38.2 d](/filings/0000875357-26-000048.md) |
| Share repurchases | $m | [59.5 d](/filings/0000875357-24-000050.md) | [50.2 d](/filings/0000875357-26-000013.md) | [52.2](/filings/0000875357-25-000027.md) | [37.6 d](/filings/0000875357-25-000045.md) | [0.0 d](/filings/0000875357-25-000057.md) | [0.1 d](/filings/0000875357-26-000013.md) | [1.0](/filings/0000875357-26-000034.md) | [62.8 d](/filings/0000875357-26-000048.md) | [41.0 d](/filings/0000875357-25-000057.md) | [308 d](/filings/0000875357-26-000013.md) | [0.0](/filings/0000875357-26-000034.md) | [8.2 d](/filings/0000875357-26-000048.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [67.0](/filings/0000875357-23-000046.md) | [66.3](/filings/0000875357-24-000023.md) | [66.0](/filings/0000875357-24-000041.md) | [65.5](/filings/0000875357-24-000050.md) | [64.3](/filings/0000875357-25-000027.md) | [63.7](/filings/0000875357-25-000045.md) | [63.5](/filings/0000875357-25-000057.md) | [63.5](/filings/0000875357-26-000034.md) | [63.2](/filings/0000875357-26-000048.md) | [62.8](/filings/0000875357-25-000057.md) | [60.0](/filings/0000875357-26-000034.md) | [60.1](/filings/0000875357-26-000048.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 60,766,867 at 2026-06-30, from the cover of the [10-Q filed 2026-08-04](/filings/0000875357-26-000048.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.